Literature DB >> 29271714

A propensity score analysis of the impact of surgical intervention on unexpected 30-day readmission following admission for subdural hematoma.

Lynze R Franko1, Kyle M Sheehan2,3, Christopher D Roark4, Jacob R Joseph2, James F Burke3, Venkatakrishna Rajajee2,3, Craig A Williamson2,3.   

Abstract

OBJECTIVE: Subdural hematoma (SDH) is a common disease that is increasingly being managed nonoperatively. The all-cause readmission rate for SDH has not previously been described. This study seeks to describe the incidence of unexpected 30-day readmission in a cohort of patients admitted to an academic neurosurgical center. Additionally, the relationship between operative management, clinical outcome, and unexpected readmission is explored.
METHODS: This is an observational study of 200 consecutive adult patients with SDH admitted to the neurosurgical ICU of an academic medical center. Demographic information, clinical characteristics, and treatment strategies were compared between readmitted and nonreadmitted patients. Multivariable logistic regression, weighted by the inverse probability of receiving surgery using propensity scores, was used to evaluate the association between operative management and unexpected readmission.
RESULTS: Of 200 total patients, 18 (9%) died during hospitalization and were not included in the analysis. Overall, 48 patients (26%) were unexpectedly readmitted within 30 days. Sixteen patients (33.3%) underwent SDH evacuation during their readmission. Factors significantly associated with unexpected readmission were nonoperative management (72.9% vs 54.5%, p = 0.03) and female sex (50.0% vs 32.1%, p = 0.03). In logistic regression analysis weighted by the inverse probability of treatment and including likely confounders, surgical management was not associated with likelihood of a good outcome at hospital discharge, but was associated with significantly reduced odds of unexpected readmission (OR 0.19, 95% CI 0.08-0.49).
CONCLUSIONS: Over 25% of SDH patients admitted to an academic neurosurgical ICU were unexpectedly readmitted within 30 days. Nonoperative management does not affect outcome at hospital discharge but is significantly associated with readmission, even when accounting for the probability of treatment by propensity score weighted logistic regression. Additional research is needed to validate these results and to further characterize the impact of nonoperative management on long-term costs and clinical outcomes.

Entities:  

Keywords:  CCI = Charlson Comorbidity Index; CHF = congestive heart failure; GCS = Glasgow Coma Scale; GOS = Glasgow Outcome Scale; ICU = intensive care unit; IQR = interquartile range; SDH = subdural hematoma; acute subdural hematoma; chronic subdural hematoma; intracranial subdural hematoma; patient readmission; trauma; traumatic subdural hematoma

Mesh:

Year:  2017        PMID: 29271714     DOI: 10.3171/2017.6.JNS17188

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Midline Shift vs. Mid-Surface Shift: Correlation with Outcome of Traumatic Brain Injuries.

Authors:  Cheng Jiang; Jie Cao; Craig Williamson; Negar Farzaneh; Venkatakrishna Rajajee; Jonathan Gryak; Kayvan Najarian; S M Reza Soroushmehr
Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)       Date:  2020-02-06

2.  Readmissions after nonoperative trauma: Increased mortality and costs with delayed intervention.

Authors:  Marta L McCrum; Chong Zhang; Angela P Presson; Raminder Nirula
Journal:  J Trauma Acute Care Surg       Date:  2020-02       Impact factor: 3.697

3.  Regional Variation in the Management of Nontraumatic Subdural Hematomas Across the United States.

Authors:  David Robinson; Jane C Khoury; Dawn Kleindorfer
Journal:  World Neurosurg       Date:  2019-12-17       Impact factor: 2.104

4.  Importance of effusion of blood under the dura mater in forensic medicine: A STROBE - compliant retrospective study.

Authors:  Sigitas Chmieliauskas; Joginte Saule Anuzyte; Julita Liucvaikyte; Sigitas Laima; Eleonora Jurolaic; Saulius Rocka; Dmitrij Fomin; Jurgita Stasiuniene; Algimantas Jasulaitis
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.